期刊文献+

顶空气相色谱法测定托拉塞米中7种有机溶剂残留量 被引量:1

Determination of seven residual organic solvents in torasemide by headspace capillary gas chromatography
下载PDF
导出
摘要 目的建立托拉塞米中9种有机溶剂残留量的测定方法。方法采用顶空毛细管气相色谱法,以二甲基亚砜为溶剂,DB-624色谱柱(30m×0.32mm×0.250μm),FID检测器。结果 7种残留有机溶剂甲醇、乙醇、丙酮、二氯甲烷、正丙醇、二氧六环、甲苯均达到了完全分离。结论该方法灵敏度、准确度均达到有机溶剂残留量的检测要求,可用于托拉塞米中7种残留溶剂的同时检测。 OBJECTIVE To develop a headspace capillary gas chromatography for determining the residual organic solvents methanol,ethanol,acetone,dichloromethane,n-propanol,dioxane and toluene in torasemide.METHODS The samples were dissolved in dimethyl sulfoxide.The nine organic solvents were separated on a DB-624 capillary colunn(30m×0.32mm×0.250μm)using programmable increased temperature.The intial temperature was kept at 40℃ for 30min.The temperature was raised to 180℃ at the rate of 20℃·min-1.RESULTS Seven residual organic solvents consisting of methanol,ethanol,acetone,dichloromethane,n-propanol,dioxane and toluene in Torasemide were completely separated,and the samples coincided with the requirements.CONCLUSION The methods was proved to be accurate and sensitive after validation.It is suitable to the determination of residual organic solvents in Torasemide.
作者 黄榕珍 修虹
出处 《海峡药学》 2012年第3期49-51,共3页 Strait Pharmaceutical Journal
关键词 顶空气相色谱法 残留有机溶剂 托拉塞米 Headspace capillary gas chromatography Residual organic solvents Torssemide
  • 相关文献

参考文献4

二级参考文献40

  • 1陈新谦 金有豫.新编药物学(第14版)[M].北京:人民卫生出版社,1997.487.
  • 2[1][1] Blose JS,Adams KF Jr,Patterson JH. Torsemide:a pyridine-sulfonylurea loop diuretic[J]. Ann Pharmacother, 1995,29(4): 396 - 402.
  • 3[2]Brater DC. Clinical pharmacology of loop diuretics [J]. Drugs,1991,41 (Suppl 3) :S14 - S22.
  • 4[3]Frieder HA,Buckley MM-T. Torasemide-a review of its pharmacology, properties and therapeutic potential [J]. Drugs, 1991,41(1) :S81 - S103.
  • 5[4]Bart WH,Smith HL,Karnes HT,et al.Torasemide dose proportionality of pharmacokinetics and pharmacodynamics [J]. Prog Pharmacol Clin Pharmacol, 1990,8: 29 - 37.
  • 6[5]Fowler SF, Murray KM. Torsemide: A new loop diruetic [J].Am J Health-Syst Pharm, 1995,52(15): 1771 - 1780.
  • 7[6]Knauf H,Spahn H,Mutschler E. The loop diuretic torasemide in chronic renal failure: pharmacokinetics and pharmacodynamics [J]. Drugs, 1991,41 (Suppl 3) :S23 - S34.
  • 8[7]Kido H,Ohtaki Y. Torasemide (LUPRAC) :a review of its pharmacological and clinical profile[J]. Nippon Yakeurigaku Zasshi,2001,118(2):97- 105.
  • 9[8]Kruck F. Acute and long term effects of loop diuretics in heart failure[J]. Drugs, 1991,41 (Suppl 3): S60 - S68.
  • 10[9]Barr WH,Smith HL,Karnes HT,et al. Comparison of bioavailability, pharmacokinetics and pharmacodynamics of torasemide in young and elderly healthy volunteers[J]. Prog Pharmacol Clin Pharmmol, 1990 ;8:15 - 28.

共引文献45

同被引文献13

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部